P14: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA

• S Usmani,
• A Alonso,
• H Quach,
• Y Koh,
• A Guenther,
• CK Min,
• X Leleu,
• AO Abdallah,
• A Oriol,
• B Bessemer,
• M Garg,
• I Sandhu,
• K Weisel,
• E Ocio San Miguel,
• M Cavo,
• X Zhou,
• M Kaisermann,
• L Mis,
• D Williams,
• A Yeakey,
• G Ferron-Brady,
• D Figueroa,
• B Kremer,
• I Gupta,
• W Janowski

Affiliations

S Usmani

1 Levine Cancer Institute, Charlotte (USA)

A Alonso

2 Hospital Quirón Madrid, Madrid (Spain)

H Quach

3 St Vincent’s Hospital Melbourne, Melbourne (Australia)

Y Koh

4 Seoul National University Hospital, Seoul (South Korea)

A Guenther

5 Helios Kliniken Schwerin GmbH, Schwerin (Germany)

CK Min

6 The Catholic University of Korea Seoul St. Mary’s Hospital, Seoul (South Korea)

X Leleu

7 CHU de Poitiers, Poitiers (France)

AO Abdallah

8 University of Kansas, Kansas City (USA)

A Oriol

9 Institut Catala d’Oncologia (ICO) -Hospital Universitari Germans Triasi Pujol (HUGTP), Badalona (Spain)

B Bessemer

10 University of Tuebingen, Tübingen (Germany)

M Garg

11 Leicester Royal Infirmary, Leicester, (UK)

I Sandhu

12 University of Alberta, Edmonton (Canada)

K Weisel

13 University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

E Ocio San Miguel

14 Hospital Universitario Marqués de Valdecilla (IDIVAL), University of Cantabria, Santander (Spain)

M Cavo

15 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istitutodi Ematologia “Seràgnoli”, Universitàdegli Studi di Bologna, Bologna (Italy)

X Zhou

16 GlaxoSmithKline, Waltham (USA), 16†Mississauga (Canada), 16‡Research Triangle Park (USA)

M Kaisermann

16 GlaxoSmithKline, Waltham (USA), 16†Mississauga (Canada), 16‡Research Triangle Park (USA)

L Mis

16 GlaxoSmithKline, Waltham (USA), 16†Mississauga (Canada), 16‡Research Triangle Park (USA)

D Williams

16 GlaxoSmithKline, Waltham (USA), 16†Mississauga (Canada), 16‡Research Triangle Park (USA)

A Yeakey

16 GlaxoSmithKline, Waltham (USA), 16†Mississauga (Canada), 16‡Research Triangle Park (USA)

G Ferron-Brady

16 GlaxoSmithKline, Waltham (USA), 16†Mississauga (Canada), 16‡Research Triangle Park (USA)

D Figueroa

16 GlaxoSmithKline, Waltham (USA), 16†Mississauga (Canada), 16‡Research Triangle Park (USA)

B Kremer

16 GlaxoSmithKline, Waltham (USA), 16†Mississauga (Canada), 16‡Research Triangle Park (USA)

I Gupta

16 GlaxoSmithKline, Waltham (USA), 16†Mississauga (Canada), 16‡Research Triangle Park (USA)

W Janowski

17 Calvary Mater Newcastle, Newcastle (Australia).